Lv3
202 积分 2023-02-28 加入
Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice
1天前
待确认
Recent trends and advances in novel formulations as an armament in Bcl-2/Bax targeted breast cancer
16天前
已完结
Recent advances in canonical versus non-canonical Ca2+-signaling-related anti-apoptotic Bcl-2 functions and prospects for cancer treatment
16天前
已完结
First BCL-2 Inhibitor Approved for Mantle Cell Lymphoma
22天前
已关闭
Sonrotoclax: First Approval
22天前
已完结
Lisaftoclax: First Approval
22天前
已完结
How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor
22天前
已完结
Recent advances of small-molecule Mcl-1 inhibitors or degraders as promising anti-cancer agents (2018-present)
23天前
已完结
SOHO State of the Art Updates and Next Questions: Understanding and Overcoming Venetoclax Resistance in Hematologic Malignancies
23天前
已完结
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia
23天前
已完结
皖公网安备34019202002308
